{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigcw3wruewqpx4hko3u453pi7cwmy7cgyzibblacg53t65tzuucf4",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mk57jo73ix62"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicda3fadw6ukein7bxvdiy5ci2zvipmi3c6cch2xu5vpupw2nvora"
    },
    "mimeType": "image/jpeg",
    "size": 150305
  },
  "path": "/2026/04/22/gene-therapy-deafness-otof-gene-targeted-impressive-trial-results/?utm_campaign=rss",
  "publishedAt": "2026-04-22T15:00:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Clinical trials",
    "disability",
    "Gene therapy",
    "STAT+"
  ],
  "textContent": "After gene therapy for a rare form of deafness, 90% of participants in a clinical trial in China had significant improvement in hearing.",
  "title": "STAT+: Gene therapy trial for deafness adds evidence to drug’s efficacy",
  "updatedAt": "2026-04-22T19:05:32.000Z"
}